SLDB · NASDAQ · Biotechnology

Solid Biosciences (SLDB)

Advancing gene therapy candidates for Duchenne and other rare neuromuscular and cardiac diseases.

$8.92
After hours+0.02 (+0.17%)
At close$8.91(+4.27%)